TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Tagamet Hydrochloride In Sodium Chloride 0.9% In Plastic Container patents expire, and when can generic versions of Tagamet Hydrochloride In Sodium Chloride 0.9% In Plastic Container launch?
Tagamet Hydrochloride In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What are the global sales for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER?
Summary for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Clinical Trials: | 7 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed |
![TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER drug patent expirations Drug patent expirations by year for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER](/p/graph/s/t/TAGAMET_HYDROCHLORIDE_IN_SODIUM_CHLORIDE_0.9%_IN_PLASTIC_CONTAINER-patent-expirations.png)
Recent Clinical Trials for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Washington | Phase 4 |
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 |
National Institutes of Health (NIH) | Early Phase 1 |
See all TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 019434-001 | Oct 31, 1985 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 019434-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 019434-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Glaxosmithkline | TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 019434-001 | Oct 31, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
See the table below for patents covering TAGAMET HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S5243833 | ⤷ Sign Up | |
Argentina | 197093 | PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE GUANIDINA FARMACOLOGICAMENTE ACTIVOS | ⤷ Sign Up |
Finland | 68617 | ⤷ Sign Up | |
Sweden | 410103 | FORFARANDE FOR FRAMSTELLNING AV FORENINGAR, VILKA ER ANTAGONISTER MOT VISSA VERKNINGAR AV HISTAMIN | ⤷ Sign Up |
Japan | S579765 | MANUFACTURE OF HETEROCYCLIC COMPOUND | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |